Search Results - "Furman, N V"

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) by Reshetko, O. V., Sokolov, A. V., Furman, N. V., Agapov, V. V.

“…Aim . To study the changes that have occurred in the pharmacotherapy of atrial fibrillation (AF) in the Saratov Region for 5 years by analyzing the…”
Get full text

The “Inverse” Seasonal Blood Pressure Variability Phenotype by Gorbunov, V. M., Smirnova, M. I., Koshelyaevskaya, Y. N., Panueva, N. N., Furman, N. V., Dolotovskaya, P. V.

“…The seasonal blood pressure variability (BPV) is known to demonstrate a typical winter peak. Recently, more attention is paid to the opposite situation: the…”
Get full text

Radiofrequency ablation of the ectopic activity zone in a patient with long-standing chronic right-side inferioatrial tachycardia by Morozov, I A, Furman, N V, Oleĭnik, G S, Merkushova, I M

“…To illustrate feasibility of successful correction of chronic long-standing right-side inferioatrial tachycardia (RIT). A case report of examination and…”
Get full text

Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach by Smirnova, М. I., Gorbunov, V. M., Koshelyaevskaya, Ya. N., Deev, A. D., Volkov, D. A., Furman, N. V., Dolotovskaya, P. V.

“…Background. Early diagnostics of masked hypertension (MH) is one of the key problems in modern cardiology due to the association of this blood pressure (BP)…”
Get full text

ADP-Induced Recalcified Blood Clotting Time as a Marker of Rethrombosis Risk and Effectiveness of Antiplatelet Therapy in Acute Coronary Syndrome by Malinova, L I, Furman, N V, Dolotovskaya, P V, Chernousova, L A, Denisova, T P

“…to assess the possibility of the use of ADP induced blood-clotting time measurement in clinical practice prognostication of the course of acute coronary…”
Get more information

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION by Furman, N. V., Shmatova, S. S.

“…Interval QT prolongation is a predictor of the life-threatening cardiac arrhythmias — polymorphic ventricular tachycardia (torsade de pointes). Long QT…”
Get full text

COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 by Reshetko, O. V., Sokolov, A. V., Rykalina, E. V., Furman, N. V.

“…Aim. To compare features of pharmacotherapy of patients with chronic heart failure (CHF) with a reduced ejection fraction of the left ventricle (LV EF) who…”
Get full text

ANTIPLATELET TREATMENT IN ST ELEVATION ACUTE CORONARY SYNDROME UNDER REAL CLINICAL CIRCUMSTANCES: THE DYNAMICS OF THROMBOCYTE FUNCTION by Malinova, L. I., Furman, N. V., Dolotovskaya, P. V., Puchinian, N. F., Radaeva, I. Yu

“…Aim. To evaluate the dynamics of thrombocyte functional activity (TFA) under antiplatelet treatment conditions which include the branded, and generic compounds…”
Get full text

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by Puchinian, N. F., Furman, N. V., Malinova, L. I., Dolotovskaya, P. V.

“…Monitoring of the effectiveness of drug therapy is one of the most debated issues in everyday clinical practice. The emergence of new drugs,  methods of…”
Get full text

High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice by Puchinyan, N. F., Furman, N. V., Dolotovskaya, P. V., Malinova, L. L.

“…Aim. To study the prevalence of high residual platelet reactivity (HRPR) during the dual antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and…”
Get full text

A CASE OF PAINLESS MYOCARDIAL INFARCTION DUE TO BRIDGING OF LEFT ANTERIOR DESCENDING ARTERY by Bogomolova, O. S., Furman, N. V., Titkov, I. V.

“…Myocardial bridging (MB) is congenital abnormality of the coronary arteries, which typically does not interfere with long term prognosis, but in some cases can…”
Get full text

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION by Mikheeva, N. V., Reshetko, O. V., Furman, N. V.

“…Aim. To analyze pharmacotherapy of cerebral infarction in patients with atrial fibrillation (AF) in real clinical practice of neurological departments of…”
Get full text

Potential utility of optic aggregometry for identification of patients with coronary heart disease resistant to acetylsalicylic acid by Puchin'ian, N F, Furman, N V, Dovgalevskiĭ, Ia P

“…We estimated potential of optic aggregometry for the identification of patients with coronary heart disease in 271 patients with coronary heart disease (CHD)…”
Get more information

EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA by Boytsov, S. A., Loukianov, M. M., Platonova, E. V., Gorbunov, V. M., Romanchuk, S. V., Nazarova, O. A., Belova, O. A., Kravtsova, E. A., Dovgalevsky, P. Ya, Furman, N. V., Mironova, A. A., Dolotovskaya, P. V., Nekrasov, A. V., Puchkova, N. G., Abramova, M. A., Belova, E. N., Klyashtorny, V. G., Deev, A. D.

“…Aim. To estimate an efficiency of influenza vaccination in patients with circulatory system diseases diseases (CSD) under 3-year follow-up in outpatient…”
Get full text

Spontaneous dissection of coronary artery as a cause of acute myocardial infarction by Protasova, E. A., Furman, N. V., Titkov, I. V., Oleynik, A. O., Gusev, K. V.

“…Spontaneous dissection of coronary arteries (SDCA) is a rare cause factor for acute myocardial infarction. The data provided is modern on the prevalence of…”
Get full text

Gender related characteristics of clinical status and pharmacotherapy of patients with paroxysmal and persistent atrial fibrillation by Furman, N V, Graĭfer, I V, Reshet'ko, O V, Dolotovskaia, P V

“…Aim of the study was to elucidate gender related characteristics of clinical status and treatment of patients with atrial fibrillation (AF) hospitalized in a…”
Get more information

Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation by Furman, N V, Kuvshinova, L E, Dovgalevskiĭ, Ia P

“…We present data on possibility of anticoagulant therapy in conjunction with electrical cardioversion in patients with atrial fibrillation using novel…”
Get more information

PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE by Dolotovskaya, P. V., Rudnichenko, E. Y., Furman, N. V., Reshet'ko, O. V.

“…Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real…”
Get full text

RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME AND HIGH PLASMA LEVELS OF D-DIMER by Panina, A. V., Puchinyan, N. F., Dovgalevskyi, Ya. P., Furman, N. V., Dolotovskaya, P. V., Malinova, L. I.

“…Aim. To study the association of plasma D-dimer levels and the risk of thrombotic events in patients hospitalised with acute coronary syndrome (ACS). Material…”
Get full text

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE by Kuvshinova, L. E., Furman, N. V., Dolotovskaya, P. V., Dovgalevsky, Ya. P.

“…Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for…”
Get full text